Quantcast

Industry news that matters to you.  Learn more

BIDMC Researchers Identify Possible Biomarker for Parkinson’s Disease

Although Parkinson’s disease is the second most prevalent neurodegenerative disorder in the U.S., there are no standard clinical tests available to identify this widespread condition. As a result, Parkinson’s disease often goes unrecognized until late in its progression, when the brain’s affected neurons have already been destroyed and telltale motor symptoms such as tremor and rigidity have already appeared.

Hyperion Medical Introduces the Sudoscan

Hyperion Medical is recently announced the availability of the FDA approved SudoScan device to the medical community. The SudoScan device is a new solution for Sudorimetry, measuring of the sweat gland function as a biomarker for autonomic nervous system (ANS) function.